Claventin and hepatocellular damage Patient Reports February 13, 2012

Claventin Side Effects Report #5075823-9
Claventin side effect was reported by a Consumer or non-health professional from FRANCE on Aug 03, 2006. Female patient, 57 years of age, was treated with Claventin. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, cardiac failure congestive, hepatocellular damage, hyperkalaemia, prothrombin level decreased, respiratory distress. Claventin dosage: unknown. During the same period patient was treated with IMUREL. Patient was hospitalized. Patient recovered.

Claventin Side Effects Report #5168230-1
Claventin side effect was reported by a Consumer or non-health professional from FRANCE on Aug 03, 2006. Female patient, 57 years of age, was treated with Claventin. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, blood lactate dehydrogenase increased, cardiac failure congestive, hepatic failure, hepatocellular damage, hyperkalaemia, prothrombin level decreased. Claventin dosage: unknown. During the same period patient was treated with IMUREL. Patient was hospitalized. Patient recovered.